Hikal Ltd.

NSE: HIKAL | BSE: 524735 | ISIN: INE475B01022 | Industry: Pharmaceuticals
| Expensive Star
416.7000 -8.95 (-2.10%)
NSE Apr 04, 2025 11:23 AM
Volume: 429.1K
 

logo
Hikal Ltd.
19 Sep 2018
416.70
-2.10%
ICICI Securities Limited
We met the management of Hikal Ltd (Hikal) to gain an insight into the company's pharma and agrochem businesses. Established in 1988, Hikal is a B2B player, which provides active ingredients, intermediates and R&D; services to global pharmaceuticals, animal health, crop protection and specialty chemicals companies. For FY18, pharma and agrochem accounted for 58% and 42%, respectively, of total operating revenues. The pharma business is currently divided almost equally between generic active pharma ingredients (APIs) and contract research and...
Hikal Ltd. has gained 44.36% in the last 1 Year
More from Hikal Ltd.
Recommended